Zhou, Mengshi <br/><br/>
Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer's disease in patients with rheumatoid arthritis and psoriasis.  [electronic resource] 

 -  PloS one  2020 
 - e0229819 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0229819  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab--therapeutic use<br/>Adolescent<br/>Adult<br/>Aged<br/>Alzheimer Disease--epidemiology<br/>Antirheumatic Agents--therapeutic use<br/>Arthritis, Psoriatic--drug therapy<br/>Arthritis, Rheumatoid--drug therapy<br/>Case-Control Studies<br/>Colitis, Ulcerative--drug therapy<br/>Etanercept--therapeutic use<br/>Female<br/>Humans<br/>Infliximab--therapeutic use<br/>Male<br/>Methotrexate--therapeutic use<br/>Middle Aged<br/>Retrospective Studies<br/>Risk<br/>Tumor Necrosis Factor Inhibitors--therapeutic use<br/>Young Adult